HOFA Gallery
5.12.2023 14:20:38 CET | ACCESS Newswire | Press release
BREAKFAST, in collaboration with HOFA Gallery and Art Miami, is set to unveil the highly anticipated 'Flashbacks, Green Lines' - an immersive kinetic installation at Art Miami 2023. BREAKFAST has recently garnered acclaim for creating the world's largest computer-controlled kinetic sculpture. Art Miami's groundbreaking installation will be on public display from 5 to 10 December 2023, offering a unique narrative where each viewer's interaction with the artwork becomes an integral part of the captivating 'Flashback, Green Lines' installation
MIAMI, FL / ACCESSWIRE / December 5, 2023 / Art Miami is poised to host a captivating immersive art installation titled 'Flashbacks, Green Lines' by BREAKFAST, in collaboration HOFA Gallery and Art Miami. This groundbreaking showcase will fuse kinetics and art, offering a unique and interactive perspective on the convergence of art and memory. Positioned prominently at the entrance of the renowned art fair, the installation invites the public to experience its unique narrative from 5 - 10 December 2023.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.BREAKFAST, 'Flashbacks, Green Lines', 2023 Flip-discs, software, camera, computer 122 x 122 in (310 x 310 cm)
BREAKFAST is renowned for their digitally driven kinetic sculptures and has recently garnered global recognition for their masterpiece, 'The Pearl' - the world's largest computer-controlled kinetic sculpture, slated to launch in 2024.
BREAKFAST's interactive installation at Art Miami, 'Flashbacks, Green Lines' promises a unique engagement with each participant. This innovative piece will record a brief clip of everyone who interacts with it, replaying these moments from the artwork's memory through mesmerising and dynamic flip-discs. 'Flashbacks, Green Lines' transcends the traditional viewer-artwork dynamic, transforming each participant into an integral part of the artistic experience. It extends an invitation to reflect on how individual curiosity, movements, and mere presence contribute to the vibrant life of the artwork.
Nick Korniloff, Director Art Miami, says about the forthcoming collaboration, "It is an amazing interactive installation at the entry of the Art Miami that will engage all our guests as they enter our 33rd edition of the Fair."
HOFA will proudly represent twenty-two leading contemporary artists, among them the pioneering BREAKFAST at Art Miami 2023. Renowned for being at the forefront of pushing artistic boundaries, the gallery's exhibition is a curated collection that not only showcases the exceptional talent of diverse artists but also serves as a testament to the gallery's core values, rich history, and forward-looking vision. The diverse portfolio spans various artistic disciplines, with a particular emphasis on embracing diversity and employing a multitude of techniques and creative practices.
Sougwen Chung and Krista Kim will also prominently feature in HOFA's presentation this year. Sougwen Chung's series of distinctive paintings, a result of collaboration with robotic entities, showcases the intricacies of the artist's profound research and performative practice. This unique collaboration introduces the world to a new dimension of digital consciousness, adding an innovative layer to the overarching artistic narrative. Further enriching HOFA's showcase is the debut of Krista Kim's zen-digital work during Art Miami.
HOFA Gallery, Booth AM 109, Art Miami
Artists Represented: ILHWA KIM, SOUGWEN CHUNG, ZHENG LU, VLADINSKY, ESER GÜNDÜZ, JASON SIMS, JULIAN VOSS-ANDREAE, LYÈS, BREAKFAST, MARY RONAYNE , ZHUANG HONG YI, JOSEPH KLIBANSKY, JAN KALÁB, GIANFRANCO, MEGGIATO, ROMINA RESSIA, KRISTA KIM, LI JIE, WANG ZILING, MAX PATTÉ, KOSTAS PAPAKOSTAS, MAXIM WAKULTSCHIK, SOPHIE VICTORIA.
Contact Information
Emma-Louise O'Neill
Comms & Brand Collaborations Director
emmalouise@thehouseoffineart.com
+447515136909
SOURCE: HOFA Gallery
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/813369/creators-of-the-worlds-largest-computer-driven-kinetic-sculpture-to-unveil-a-new-immersive-public-installation-at-art-miami-2023
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom